Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)

doi:10.1084/jem.184.2.647

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Loftus, D. J.
	Articles by Rivoltini, L.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Loftus, D. J.
	Articles by Rivoltini, L.


Social Bookmarking

	What's this?

ARTICLES

Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35)

DJ Loftus, C Castelli, TM Clay, P Squarcina, FM Marincola, MI Nishimura, G Parmiani, E Appella and L Rivoltini
Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

CTL reactivity to the epitope MART-1(27-35), of the melanoma (self) antigen MART-1/melan A is frequently observed in tumor-infiltrating lymphocytes and may be readily elicited from the peripheral blood of melanoma patients that express HLA-A*0201. Available data suggest that these observations contrast with those made for other HLA-A*0201- presented melanoma self antigens regarding the regularity of observed CTL responses. Based on preliminary findings, we hypothesized that the CTL response to MART-1 might be augmented in part by T cell encounters with peptides derived from sources other than MART-1, which show sequence similarity to MART-1(27-35). To test this idea, a protein database search for potential MART-1 epitope mimics was done using criteria developed from analyses of effector recognition of singly- substituted peptide analogues of MART-1(27-35). Synthetic peptides were made for a portion of the sequences retrieved; 12/40 peptides tested were able to sensitize target cells for lysis by one or more anti-MART- 1 effectors. The peptides recognized correspond to sequences occurring in a variety of proteins of viral, bacterial, and human (self) origin. One peptide derives from glycoprotein C of the common pathogen HSV-1; cells infected with recombinant vaccinia virus encoding native glycoprotein C were lysed by anti-MART-1 effectors. Our results overall indicate that sequences conforming to the A2.1 binding motif and possessing features essential to recognition by anti-MART-1 CTL occur frequently in proteins. These findings further suggest that T cells might encounter a variety of such sequences in vivo, and that epitope mimicry may play a role in modulating the CTL response to MART-1(27-35).
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Voelter, V., Rufer, N., Reynard, S., Greub, G., Brookes, R., Guillaume, P., Grosjean, F., Fagerberg, T., Michelin, O., Rowland-Jones, S., Pinilla, C., Leyvraz, S., Romero, P., Appay, V. (2008). Characterization of Melan-A reactive memory CD8+ T cells in a healthy donor. Int Immunol 20: 1087-1096 [Abstract] [Full Text]
Derre, L., Ferber, M., Touvrey, C., Devevre, E., Zoete, V., Leimgruber, A., Romero, P., Michielin, O., Levy, F., Speiser, D. E. (2007). A Novel Population of Human Melanoma-Specific CD8 T Cells Recognizes Melan-AMART-1 Immunodominant Nonapeptide but Not the Corresponding Decapeptide. J. Immunol. 179: 7635-7645 [Abstract] [Full Text]
Kudela, P., Janjic, B., Fourcade, J., Castelli, F., Andrade, P., Kirkwood, J. M., El-Hefnawy, T., Amicosante, M., Maillere, B., Zarour, H. M. (2007). Cross-Reactive CD4+ T Cells against One Immunodominant Tumor-Derived Epitope in Melanoma Patients. J. Immunol. 179: 7932-7940 [Abstract] [Full Text]
Vujanovic, L., Mandic, M., Olson, W. C., Kirkwood, J. M., Storkus, W. J. (2007). A Mycoplasma Peptide Elicits Heteroclitic CD4+ T Cell Responses against Tumor Antigen MAGE-A6. Clin. Cancer Res. 13: 6796-6806 [Abstract] [Full Text]
Lambe, T., Leung, J. C. H., Bouriez-Jones, T., Silver, K., Makinen, K., Crockford, T. L., Ferry, H., Forrester, J. V., Cornall, R. J. (2006). CD4 T Cell-Dependent Autoimmunity against a Melanocyte Neoantigen Induces Spontaneous Vitiligo and Depends upon Fas-Fas Ligand Interactions.. J. Immunol. 177: 3055-3062 [Abstract] [Full Text]
Colombetti, S., Fagerberg, T., Baumgartner, P., Chapatte, L., Speiser, D. E., Rufer, N., Michielin, O., Levy, F. (2006). Impact of Orthologous Melan-A Peptide Immunizations on the Anti-Self Melan-A/HLA-A2 T Cell Cross-Reactivity.. J. Immunol. 176: 6560-6567 [Abstract] [Full Text]
Griffioen, M., Kessler, J. H., Borghi, M., van Soest, R. A., van der Minne, C. E., Nouta, J., van der Burg, S. H., Medema, J. P., Schrier, P. I., Falkenburg, J.H. F., Osanto, S., Melief, C. J.M. (2006). Detection and Functional Analysis of CD8+ T Cells Specific for PRAME: a Target for T-Cell Therapy.. Clin. Cancer Res. 12: 3130-3136 [Abstract] [Full Text]
Lugini, L., Matarrese, P., Tinari, A., Lozupone, F., Federici, C., Iessi, E., Gentile, M., Luciani, F., Parmiani, G., Rivoltini, L., Malorni, W., Fais, S. (2006). Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells.. Cancer Res. 66: 3629-3638 [Abstract] [Full Text]
Bae, J., Martinson, J. A., Klingemann, H. G. (2004). Heteroclitic CD33 Peptide With Enhanced Anti-Acute Myeloid Leukemic Immunogenicity. Clin. Cancer Res. 10: 7043-7052 [Abstract] [Full Text]
Rentzsch, C., Kayser, S., Stumm, S., Watermann, I., Walter, S., Stevanovic, S., Wallwiener, D., Guckel, B. (2003). Evaluation of Pre-existent Immunity in Patients with Primary Breast Cancer: Molecular and Cellular Assays to Quantify Antigen-Specific T Lymphocytes in Peripheral Blood Mononuclear Cells. Clin. Cancer Res. 9: 4376-4386 [Abstract] [Full Text]
Ramakrishna, V., Ross, M. M., Petersson, M., Gatlin, C. C., Lyons, C. E., Miller, C. L., Myers, H. E., McDaniel, M., Karns, L. R., Kiessling, R., Parmiani, G., Flyer, D. C. (2003). Naturally occurring peptides associated with HLA-A2 in ovarian cancer cell lines identified by mass spectrometry are targets of HLA-A2-restricted cytotoxic T cells. Int Immunol 15: 751-763 [Abstract] [Full Text]
Nilges, K., Hohn, H., Pilch, H., Neukirch, C., Freitag, K., Talbot, P. J., Maeurer, M. J. (2003). Human Papillomavirus Type 16 E7 Peptide-Directed CD8+ T Cells from Patients with Cervical Cancer Are Cross-Reactive with the Coronavirus NS2 Protein. J. Virol. 77: 5464-5474 [Abstract] [Full Text]
Carrabba, M. G., Castelli, C., Maeurer, M. J., Squarcina, P., Cova, A., Pilla, L., Renkvist, N., Parmiani, G., Rivoltini, L. (2003). Suboptimal Activation of CD8+ T Cells by Melanoma-derived Altered Peptide Ligands: Role of Melan-A/MART-1 Optimized Analogues. Cancer Res. 63: 1560-1567 [Abstract] [Full Text]
Mantovani, S., Palermo, B., Garbelli, S., Campanelli, R., Robustelli della Cuna, G., Gennari, R., Benvenuto, F., Lantelme, E., Giachino, C. (2002). Dominant TCR-{alpha} Requirements for a Self Antigen Recognition in Humans. J. Immunol. 169: 6253-6260 [Abstract] [Full Text]
Rubio-Godoy, V., Dutoit, V., Zhao, Y., Simon, R., Guillaume, P., Houghten, R., Romero, P., Cerottini, J.-C., Pinilla, C., Valmori, D. (2002). Positional Scanning-Synthetic Peptide Library-Based Analysis of Self- and Pathogen-Derived Peptide Cross-Reactivity with Tumor-Reactive Melan-A-Specific CTL. J. Immunol. 169: 5696-5707 [Abstract] [Full Text]
Mandruzzato, S., Rossi, E., Bernardi, F., Tosello, V., Macino, B., Basso, G., Chiarion-Sileni, V., Rossi, C. R., Montesco, C., Zanovello, P. (2002). Large and Dissimilar Repertoire of Melan-A/MART-1-Specific CTL in Metastatic Lesions and Blood of a Melanoma Patient. J. Immunol. 169: 4017-4024 [Abstract] [Full Text]
Dutoit, V., Rubio-Godoy, V., Pittet, M. J., Zippelius, A., Dietrich, P.-Y., Legal, F. A., Guillaume, P., Romero, P., Cerottini, J.-C., Houghten, R. A., Pinilla, C., Valmori, D. (2002). Degeneracy of Antigen Recognition as the Molecular Basis for the High Frequency of Naive A2/Melan-A Peptide Multimer+ CD8+ T Cells in Humans. J. Exp. Med. 196: 207-216 [Abstract] [Full Text]
Zippelius, A., Pittet, M. J., Batard, P., Rufer, N., de Smedt, M., Guillaume, P., Ellefsen, K., Valmori, D., Lienard, D., Plum, J., MacDonald, H. R., Speiser, D. E., Cerottini, J.-C., Romero, P. (2002). Thymic Selection Generates a Large T Cell Pool Recognizing a Self-Peptide in Humans. J. Exp. Med. 195: 485-494 [Abstract] [Full Text]
Hoffmann, T. K., Loftus, D. J., Nakano, K., Maeurer, M. J., Chikamatsu, K., Appella, E., Whiteside, T. L., DeLeo, A. B. (2002). The Ability of Variant Peptides to Reverse the Nonresponsiveness of T Lymphocytes to the Wild-Type Sequence p53264-272 Epitope. J. Immunol. 168: 1338-1347 [Abstract] [Full Text]
Buslepp, J., Zhao, R., Donnini, D., Loftus, D., Saad, M., Appella, E., Collins, E. J. (2001). T Cell Activity Correlates with Oligomeric Peptide-Major Histocompatibility Complex Binding on T Cell Surface. J. Biol. Chem. 276: 47320-47328 [Abstract] [Full Text]
Salio, M., Shepherd, D., Dunbar, P. R., Palmowski, M., Murphy, K., Wu, L., Cerundolo, V. (2001). Mature Dendritic Cells Prime Functionally Superior Melan-A-Specific CD8+ Lymphocytes as Compared with Nonprofessional APC. J. Immunol. 167: 1188-1197 [Abstract] [Full Text]
Pinilla, C., Rubio-Godoy, V., Dutoit, V., Guillaume, P., Simon, R., Zhao, Y., Houghten, R. A., Cerottini, J.-C., Romero, P., Valmori, D. (2001). Combinatorial Peptide Libraries as an Alternative Approach to the Identification of Ligands for Tumor-reactive Cytolytic T Lymphocytes. Cancer Res. 61: 5153-5160 [Abstract] [Full Text]
Koelle, D. M., Chen, H. B., Gavin, M. A., Wald, A., Kwok, W. W., Corey, L. (2001). CD8 CTL from Genital Herpes Simplex Lesions: Recognition of Viral Tegument and Immediate Early Proteins and Lysis of Infected Cutaneous Cells. J. Immunol. 166: 4049-4058 [Abstract] [Full Text]
Dietrich, P.-Y., Walker, P. R., Quiquerez, A.-L., Perrin, G., Dutoit, V., Liénard, D., Guillaume, P., Cerottini, J.-C., Romero, P., Valmori, D. (2001). Melanoma Patients Respond to a Cytotoxic T Lymphocyte-defined Self-Peptide with Diverse and Nonoverlapping T-Cell Receptor Repertoires. Cancer Res. 61: 2047-2054 [Abstract] [Full Text]
Dunbar, P. R., Smith, C. L., Chao, D., Salio, M., Shepherd, D., Mirza, F., Lipp, M., Lanzavecchia, A., Sallusto, F., Evans, A., Russell-Jones, R., Harris, A. L., Cerundolo, V. (2000). A Shift in the Phenotype of Melan-A-Specific CTL Identifies Melanoma Patients with an Active Tumor-Specific Immune Response. J. Immunol. 165: 6644-6652 [Abstract] [Full Text]
Panelli, M. C., Bettinotti, M. P., Lally, K., Ohnmacht, G. A., Li, Y., Robbins, P., Riker, A., Rosenberg, S. A., Marincola, F. M. (2000). A Tumor-Infiltrating Lymphocyte from a Melanoma Metastasis with Decreased Expression of Melanoma Differentiation Antigens Recognizes MAGE-12. J. Immunol. 164: 4382-4392 [Abstract] [Full Text]
Nishimura, M. I., Avichezer, D., Custer, M. C., Lee, C. S., Chen, C., Parkhurst, M. R., Diamond, R. A., Robbins, P. F., Schwartzentruber, D. J., Rosenberg, S. A. (1999). MHC Class I-restricted Recognition of a Melanoma Antigen by a Human CD4+ Tumor Infiltrating Lymphocyte. Cancer Res. 59: 6230-6238 [Abstract] [Full Text]
Whelan, J. A., Dunbar, P. R., Price, D. A., Purbhoo, M. A., Lechner, F., Ogg, G. S., Griffiths, G., Phillips, R. E., Cerundolo, V., Sewell, A. K. (1999). Specificity of CTL Interactions with Peptide-MHC Class I Tetrameric Complexes Is Temperature Dependent. J. Immunol. 163: 4342-4348 [Abstract] [Full Text]
Wang, R., Wang-Zhu, Y., Gabaglia, C. R., Kimachi, K., Grey, H. M. (1999). The Stimulation of Low-Affinity, Nontolerized Clones by Heteroclitic Antigen Analogues Causes the Breaking of Tolerance Established to an Immunodominant T Cell Epitope. J. Exp. Med. 190: 983-994 [Abstract] [Full Text]
Wang, F., Bade, E., Kuniyoshi, C., Spears, L., Jeffery, G., Marty, V., Groshen, S., Weber, J. (1999). Phase I Trial of a MART-1 Peptide Vaccine with Incomplete Freund's Adjuvant for Resected High-Risk Melanoma. Clin. Cancer Res. 5: 2756-2765 [Abstract] [Full Text]
Anichini, A., Molla, A., Mortarini, R., Tragni, G., Bersani, I., Di Nicola, M., Gianni, A. M., Pilotti, S., Dunbar, R., Cerundolo, V., Parmiani, G. (1999). An Expanded Peripheral T Cell Population to a Cytotoxic T Lymphocyte (CTL)-defined, Melanocyte-specific Antigen in Metastatic Melanoma Patients Impacts on Generation of Peptide-specific CTLs but Does Not Overcome Tumor Escape from Immune Surveillance in Metastatic Lesions. J. Exp. Med. 190: 651-668 [Abstract] [Full Text]
Pittet, M. J., Valmori, D., Dunbar, P. R., Speiser, D. E., Lienard, D., Lejeune, F., Fleischhauer, K., Cerundolo, V., Cerottini, J.-C., Romero, P. (1999). High Frequencies of Naive Melan-A/MART-1�specific CD8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (HLA)-A2 Individuals. J. Exp. Med. 190: 705-716 [Abstract] [Full Text]
Zeh, H. J. III, Perry-Lalley, D., Dudley, M. E., Rosenberg, S. A., Yang, J. C. (1999). High Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy. J. Immunol. 162: 989-994 [Abstract] [Full Text]
Rivoltini, L., Squarcina, P., Loftus, D. J., Castelli, C., Tarsini, P., Mazzocchi, A., Rini, F., Viggiano, V., Belli, F., Parmiani, G. (1999). A Superagonist Variant of Peptide MART1/Melan A27-35 Elicits Anti-Melanoma CD8+ T Cells with Enhanced Functional Characteristics: Implication for More Effective Immunotherapy. Cancer Res. 59: 301-306 [Abstract] [Full Text]
Valmori, D., Gervois, N., Rimoldi, D., Fonteneau, J.-F., Bonelo, A., Lienard, D., Rivoltini, L., Jotereau, F., Cerottini, J.-C., Romero, P. (1998). Diversity of the Fine Specificity Displayed by HLA-A*0201-Restricted CTL Specific for the Immunodominant Melan-A/MART-1 Antigenic Peptide. J. Immunol. 161: 6956-6962 [Abstract] [Full Text]
Bettinotti, M. P., Kim, C. J., Lee, K.-H., Roden, M., Cormier, J. N., Panelli, M., Parker, K. K., Marincola, F. M. (1998). Stringent Allele/Epitope Requirements for MART-1/Melan A Immunodominance: Implications for Peptide-Based Immunotherapy. J. Immunol. 161: 877-889 [Abstract] [Full Text]
Auphan, N., Simon, A. K., Asnagli, H., Phillips, R. J., Rincon, M., Ghosh, S., Flavell, R. A., Schmitt-Verhulst, A.-M. (1998). Consequences of Intrathymic TCR Engagement by Partial Agonist on Selection Events and Peripheral T Cell Activation Program. J. Immunol. 160: 4810-4821 [Abstract] [Full Text]
Bloom, M. B., Perry-Lalley, D., Robbins, P. F., Li, Y., El-Gamil, M., Rosenberg, S. A., Yang, J. C. (1997). Identification of Tyrosinase-related Protein 2�as a Tumor Rejection Antigen for the B16 Melanoma. J. Exp. Med. 185: 453-460 [Abstract] [Full Text]